| Trial ID: | L0005 |
| Source ID: | NCT02006498
|
| Associated Drug: |
Silymarin
|
| Title: |
Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Sillymarin|Drug: Placebo
|
| Outcome Measures: |
To assess the efficacy of Silymarin as defined by an improvement in non-alcoholic steatosis (NAS) activity score by at least 30% from baseline compared to placebo|To assess the safety and adverse event profile of Silymarin compared to placebo
|
| Sponsor/Collaborators: |
University of Malaya|Rottapharm
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
99
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
June 2012
|
| Completion Date: |
December 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 8, 2016
|
| Locations: |
University Malaya Medical Centre, Kuala Lumpur, Federal Territory, Malaysia
|
| URL: |
https://ClinicalTrials.gov/show/NCT02006498
|
